MegaPro Biomedical Co Ltd Sustainability Reports
MegaPro Biomedical Co., Ltd. is a clinical-stage specialty pharmaceutical company specializing in the development of nanomedicines. Its core operations focus on creating nanoparticle and nano-micelle technology platforms for target indicators including MRI contrast agents and anti-cancer therapeutics.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG00QX1ZQ98
1 reports from 2021 to 2021
Company Profile
MegaPro Biomedical Co., Ltd. is a clinical-stage specialty pharmaceutical company specializing in the development of nanomedicines. Its core operations focus on creating nanoparticle and nano-micelle technology platforms for target indicators including MRI contrast agents and anti-cancer therapeutics.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
